Bespoke Extracts (BSPK) Notes Payables (2013 - 2025)

Bespoke Extracts (BSPK) reported Notes Payables of $25000.0 for Q3 2025, little changed on a YoY basis from $25000.0 in Q3 2024, and up 66.67% sequentially from $15000.0 in Q2 2025.

Bespoke Extracts (BSPK) Notes Payables (2013 - 2025) Analysis & Trends

Bespoke Extracts (BSPK) has 12 years of Notes Payables data on file, last reported at $25000.0 in Q3 2025.

  • For the quarter ending Q3 2025, Notes Payables changed 0.0% year-over-year to $25000.0; the trailing twelve-month figure through Sep 2025 stood at $25000.0 (changed 0.0% YoY), and the FY2024 full-year result was $20000.0, changed N/A from the prior year.
  • Notes Payables improved to $25000.0 in Q3 2025, from $15000.0 in the prior quarter.
  • In the past five years, Notes Payables ranged from a high of $692500.0 in Q1 2023 to a low of $534.0 in Q1 2021.
  • A 5-year average of $85178.0 and a median of $31475.5 in 2023 frame the typical range for Notes Payables.
  • Across the five-year window, Notes Payables tumbled 99.56% in 2021 and soared 823.33% in 2023, its largest moves.
  • Tracing BSPK's Notes Payables over 5 years: stood at $75000.0 in 2021, then climbed by 20.0% to $90000.0 in 2022, then plunged by 70.0% to $26997.0 in 2023, then declined by 25.92% to $20000.0 in 2024, then rose by 25.0% to $25000.0 in 2025.
  • Business Quant data shows BSPK's Notes Payables at $25000.0 in Q3 2025, $15000.0 in Q2 2025, and $13000.0 in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Bespoke Extracts 1.12 Mn 1.11 Mn 234,175.00

Historic Data

Download Data
DateValue
Sep 30, 2025 25,000.00
Jun 30, 2025 15,000.00
Mar 31, 2025 13,000.00
Dec 31, 2024 20,000.00
Sep 30, 2024 25,000.00
Jun 30, 2024 117,844.00
Mar 31, 2024 85,307.00
Sep 30, 2023 26,997.00
Jun 30, 2023 35,954.00
Mar 31, 2023 692,500.00
Dec 31, 2022 90,000.00
Sep 30, 2022 160,000.00
Jun 30, 2022 75,000.00
Mar 31, 2022 75,000.00
Nov 30, 2021 75,000.00
Aug 31, 2021 534.00
May 31, 2021 534.00
Feb 28, 2021 534.00
Nov 30, 2020 100,534.00
Aug 31, 2020 120,000.00